Increased Th17 and Treg levels in peripheral blood positively correlate with minimal residual disease in acute myeloid leukaemia

• Published in: Hematology (Luxembourg) Vol. 29; no. 1; p. 2346971
• Main Authors: Wang, Zhimin, Liu, Tangxia, Li, Yanru, Li, Zunchang, Bi, Kehong
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis Group 01-12-2024
• Subjects: Acute myeloid leukemia; Adolescent; Adult; Aged; Cytokines - blood; Female; Humans; Leukemia, Myeloid, Acute - blood; Leukemia, Myeloid, Acute - drug therapy; Leukemia, Myeloid, Acute - immunology; Male; Middle Aged; minimal residual disease; Neoplasm, Residual; regulatory cells; T helper cells; T-Lymphocytes, Regulatory - immunology; Th-associated cytokines; Th17 Cells - immunology; Young Adult; T helper cells; minimal residual disease; Acute myeloid leukemia; Th-associated cytokines; regulatory cells
• ISSN: 1607-8454; 1607-8454
• DOI: 10.1080/16078454.2024.2346971

Immune dysregulation plays a key role in acute myeloid leukemia (AML). We aimed to explore the correlation between T helper cell 17 (Th17) and the regulatory cells (Tregs) in the peripheral blood of patients with newly diagnosed (ND) AML and bone marrow blast cells, as well as minimal residual disease (MRD) before and after treatment.
Changes in Th17 and Treg cells in the peripheral blood of 32 patients with ND AML were observed before and after induction chemotherapy with cytarabine for seven days and anthracycline for three days. The levels of inflammatory cytokines were measured using an enzyme-linked immunosorbent assay. Correlation analysis between bone marrow blast cells and Th17 and Treg cell frequencies was performed using the Pearson's correlation test. Frequencies of Th17 and Treg cells and MRD were assessed using flow cytometry.
IL-6, IL-10, IL-17A, and GM-CSF levels gradually increased in patients with ND AML and CR and NR patients. The percentages of Th17 and Treg cells positively correlated with those of blast cells. In addition, the frequencies of Th17 and Treg cells in MRD-positive patients were higher than those in MRD-negative patients at the initial induction and after three months of chemotherapy. The frequencies of Tregs and Th17 cells positively correlated with MRD onset.
Increased Th17 and Treg cell levels were positively correlated with onset of AML, poor remission, and MRD.